Stock Analiz

Arcus Biosciences, Inc. (RCUS) stock forecast and price target

Price $17.43 · data as of November 13, 2026

12-month price target

Average target$41.00
Upside / downside+135.2%
Analysts12
ConsensusStrong buy
Low $23.00Average $41.00High $50.00

Gold marker: average target · white marker: today’s price ($17.43)

Analyst ratings

Strong buy 1Buy 12Hold 2Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-3.48−5.7%$72M
Next fiscal year
ends December 31, 2027
$-3.09+11.1%$56M
Next quarter
ends December 31, 2026
$-0.86+3.9%$6M
Quarter after
ends March 31, 2027
$-0.88+13.3%$6M

Consensus of the analysts covering Arcus Biosciences, updated daily. In the last 30 days 0 estimates were raised and 3 lowered.

Frequently asked questions

What is the Arcus Biosciences stock price target?

The average 12-month target from 12 analysts is $41.00, 135.2% above the current price of $17.43 Targets range from $23.00 to $50.00.

Is Arcus Biosciences a buy according to analysts?

The consensus rating is “Strong buy” (1 strong buy, 12 buy, 2 hold). Ratings are opinions, not guarantees; this is not investment advice.

How much is Arcus Biosciences expected to earn?

Analysts expect EPS of $-3.48 for the fiscal year ending December 31, 2026 and $-3.09 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.